Travere Therapeutics

“Travere Therapeutics is committed to developing investigational products for people living with rare disease. We believe that participating in a clinical trial is the best way for patients to access our investigational products, however, we recognize that there are situations in which patients may not be able to access our investigational products through our clinical trials. For example, some individuals may not satisfy all the eligibility conditions required to enter our clinical trial, some may have a critical need for immediate care, and some may live in a location that is not accessible a participating clinical trial site. For patients in any of these situations, we will consider requests for special access to our investigational products, which is often referred to as compassionate use or expanded access.”

There are situations in which individuals may not be able to access our investigational products through our clinical trials due to eligibility requirements or geographic distance from a clinical trial site. Some may have a critical need for immediate care. We consider requests for special access to our investigational products through our compassionate use and expanded access programs.